December 26, 2025 In this episode, Scott, Mark, and Ray Painter answer listener questions about the new 2026 prostate biopsy CPT codes. They clarify global periods, explain the differences between transrectal and transperineal approaches, and tackle the nuances of coding for MRI-guided procedures—especially when using systems like Promaxo. They also break down the use of 55715 for additional targeted lesions, when modifiers like 52 may apply, and how payers might interpret these new c...
All content for Urology Coding and Reimbursement Podcast is the property of Mark Painter, Scott Painter and Dr. Ray Painter and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
December 26, 2025 In this episode, Scott, Mark, and Ray Painter answer listener questions about the new 2026 prostate biopsy CPT codes. They clarify global periods, explain the differences between transrectal and transperineal approaches, and tackle the nuances of coding for MRI-guided procedures—especially when using systems like Promaxo. They also break down the use of 55715 for additional targeted lesions, when modifiers like 52 may apply, and how payers might interpret these new c...
UCR 249: New FDA Rulings – What It Means for Coding, Coverage, and Reimbursement
Urology Coding and Reimbursement Podcast
27 minutes
6 months ago
UCR 249: New FDA Rulings – What It Means for Coding, Coverage, and Reimbursement
June 27, 2025 Scott, Mark, and Ray discuss how new FDA rulings—like the recent update for Rezūm—impact coverage, coding, and reimbursement. They walk through the layers of medical necessity, CPT codes, payer policies, and documentation strategies needed to ensure payment. PRS Coding and Reimbursement Hub Access the Hub Free Kidney Stone Coding Calculator Download Now PRS Coding Courses For Urologist For APPs For Coders, Billers, and Admins PRS Billing and Other Services - Bo...
Urology Coding and Reimbursement Podcast
December 26, 2025 In this episode, Scott, Mark, and Ray Painter answer listener questions about the new 2026 prostate biopsy CPT codes. They clarify global periods, explain the differences between transrectal and transperineal approaches, and tackle the nuances of coding for MRI-guided procedures—especially when using systems like Promaxo. They also break down the use of 55715 for additional targeted lesions, when modifiers like 52 may apply, and how payers might interpret these new c...
